Integra LifeSciences Holdings Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Integra LifeSciences Holdings Corporation income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue1.611.541.561.541.371.521.47
Cost of Revenue0.650.660.590.600.520.560.57
Gross Profit0.960.880.970.940.850.950.90
Operating Expenses
Research & Development0.100.100.100.090.080.140.08
Selling, General & Administrative0.670.660.620.640.590.690.69
Operating Expenses0.780.770.730.750.700.860.79
Operating Income0.180.110.240.200.150.090.11
Other Income/Expense
Interest Income0.020.020.010.010.010.000.00
Interest Expense-0.07-0.05-0.050.05-0.070.000.06
Other Income/Expense-0.030.000.010.060.00-0.010.01
Income
Income Before Tax-0.020.080.210.210.090.060.06
Income Tax Expense-0.010.010.030.05-0.040.010.00
Net Income-0.010.070.180.170.130.050.06
Net Income - Continuous Operations-0.010.070.180.170.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA0.320.200.380.380.280.220.23
EBIT0.180.080.260.270.170.110.12
Depreciation & Amortization0.140.010.010.020.030.030.02
Earnings Per Share
Basic EPS-1.002.002.002.001.001.00
Diluted EPS-1.002.002.002.001.001.00
Basic Shares Outstanding0.080.080.080.080.080.090.08
Diluted Shares Outstanding0.080.080.080.090.090.090.08